Repertoire Immune Medicines Announces FDA Fast Track Designation for its Investigational Immune Medicine, RPTR-1-201

B Fast Track Designation granted for RPTR-1-201, a T cell receptor bispecific, in triple-negative breast cancer Designation underscores the potential of RPTR-1-201 to address a…
posteditor
posteditor
Articles: 21727

Other News